ABBOTT LABORATORIES — Director's Dealing 2018

Feb 1, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2018-01-30

Reporting Person: Fussell Stephen R (Executive Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-01-30	Common shares without par value	S	945	$62.8250	Disposed	152343	Direct
2018-01-30	Common shares without par value	S	3506	$62.83	Disposed	148837	Direct
2018-01-30	Common shares without par value	S	662	$62.835	Disposed	148175	Direct
2018-01-30	Common shares without par value	S	3502	$62.84	Disposed	144673	Direct
2018-01-30	Common shares without par value	S	1198	$62.845	Disposed	143475	Direct
2018-01-30	Common shares without par value	S	1400	$62.85	Disposed	142075	Direct
2018-01-30	Common shares without par value	S	600	$62.855	Disposed	141475	Direct
2018-01-30	Common shares without par value	S	700	$62.86	Disposed	140775	Direct
2018-01-30	Common shares without par value	S	600	$62.87	Disposed	140175	Direct
2018-01-30	Common shares without par value	S	200	$62.89	Disposed	139975	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	1587	Indirect
Common shares without par value	53	Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of January 31, 2018.

F2: The reporting person disclaims beneficial ownership of all securities held by his spouse.